Arava/Methotrexate Combo May Expand Indication To Refractory Patients
Executive Summary
A planned combination trial of Hoechst Marion Roussel's Arava and methotrexate in rheumatoid arthritis may justify expanding the use of leflunomide to patients not adequately controlled by methotrexate alone, HMR consultant Marc Hochberg, MD, University of Maryland, told the Arthritis Advisory Committee Aug. 7.